Interleukin 1β (IL-1β), is one of the important inflammatory markers associated with type-2 DM which in turn modifies β-cell apoptosis causing its damage subsequently affects insulin secretion [7], and suggestive that anti-inflammatory drugs can aid in diabetes management [8]. Here, INS is linked to diabetes mellitus.